Research and Development

The Research and Development team at Sparc Life focuses on small and large molecule drug discovery, CMC development, preclinical translation including NDA-enabling toxicology, and clinical development and operations. This team is instrumental in driving innovative therapies from the bench through clinical studies to regulatory approval, effectively building a robust pipeline in oncology, neurodegeneration, and immunology. Their collaborative efforts underpin Sparc Life's commitment to redefining patient care in areas of unmet need.